Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage.
about
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Primary or secondary antifunga ...... igancies: efficacy and damage.
@ast
Primary or secondary antifunga ...... igancies: efficacy and damage.
@en
Primary or secondary antifunga ...... igancies: efficacy and damage.
@nl
type
label
Primary or secondary antifunga ...... igancies: efficacy and damage.
@ast
Primary or secondary antifunga ...... igancies: efficacy and damage.
@en
Primary or secondary antifunga ...... igancies: efficacy and damage.
@nl
prefLabel
Primary or secondary antifunga ...... igancies: efficacy and damage.
@ast
Primary or secondary antifunga ...... igancies: efficacy and damage.
@en
Primary or secondary antifunga ...... igancies: efficacy and damage.
@nl
P2093
P2860
P356
P1476
Primary or secondary antifunga ...... igancies: efficacy and damage.
@en
P2093
Arzu Kantürk
Demet Aydın
Deniz Arıca
Funda Simşek
Habip Gedik
Naciye Demirel
Osman Yokuş
Taner Yıldırmak
P2860
P304
P356
10.2147/TCRM.S59683
P577
2014-04-28T00:00:00Z